Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-04

FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Butorphanol Tartrate from Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butorphanol Tartrate (Butorphanol tartrate)

Snippet

SUPPL AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)